FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097194 [Registered on: 11/11/2025] Trial Registered Prospectively
Last Modified On: 08/11/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Exploring the Effectiveness of Shortwave Diathermy in Patients with Chronic Low Back Pain 
Scientific Title of Study   Effectiveness of Shortwave Diathermy in Patients with Chronic Low Back Pain: A Randomized Single-Blinded Multicenter Clinical Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mohammad Ali 
Designation  Consultant 
Affiliation  Uttara Adhunik Medical College and Hospital 
Address  Department of Physiotherapy and Rehab, Room no-01



1230
Other 
Phone  01715043533  
Fax    
Email  drmali2008@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Mohammad Ali 
Designation  Consultant 
Affiliation  Uttara Adhunik Medical College and Hospital 
Address  Department of Physiotherapy and Rehab,Room 1



1230
Other 
Phone  01715043533  
Fax    
Email  drmali2008@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Mohammad Ali 
Designation  Consultant 
Affiliation  Uttara Adhunik Medical College and Hospital 
Address  Department of Physiotherapy and Rehab, Room 1



1230
Other 
Phone  01715043533  
Fax    
Email  drmali2008@gmail.com  
 
Source of Monetary or Material Support  
Hasna Hena Pain Physiotherapy and Public Health Research Center (HPRC), Uttara, Dhaka-1230, Bangladesh.  
 
Primary Sponsor  
Name  Mohammad Ali 
Address  Department of Physiotherapy and Rehab, Room no 1, House 34, Road 04, Sector 09, Uttara, Dhaka 1230, Bangladesh 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     Bangladesh  
Sites of Study  
No of Sites = 6  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Md Abu Alam  Ad-Din Medical College Hospital  Department of Physiotherapy, Room no 100.

 
8801515634808

mdabualamho@gmail.com 
Saddam Hossain  Asia Digital Physiotherapy and Orthopedic Rehabilitation Center   Department of Physiotherapy, Room no 1

 
8801950935236

shossainrasel@gmail.com 
Abu Bakar Arfan  Japan Bangladesh College of physiotherapy and Health sciences  Department of Physiotherapy, Room no 500

 
8801521205620

abubakarafran@gmail.com 
Mehedi Hasan  Mayfair Wellness Clinic Ltd.  Department of Physiotherapy Room no 1

 
8801682348491

mhmehedi20@gmail.com 
Md Amran Hossain  Mi care health and research   Department of physiotherapy, Room 200

 
8801920603090

imranbinnoman@gmail.com 
Mohammad Ali  Uttara Adhunik Medical College Hospital  Department of physiotherapy and rehab, room no 1

 
8801715043533

alibup2018@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 6  
Name of Committee  Approval Status 
Ethical Review Committee of Uttara Adhunik Medical College  Approved 
Ethical Review Committee of Uttara Adhunik Medical College  Approved 
Ethical Review Committee of Uttara Adhunik Medical College  Approved 
Ethical Review Committee of Uttara Adhunik Medical College  Approved 
Ethical Review Committee of Uttara Adhunik Medical College  Approved 
Ethical Review Committee of Uttara Adhunik Medical College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M472||Other spondylosis with radiculopathy, (2) ICD-10 Condition: M190||Primary osteoarthritis of other joints,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Short Wave Diathermy  - Pulsed SWD (27.12 MHz, 100–150 W, 20 min per session, 3 session per week for 4 weeks) using Webstar-500 SWD machine. - Combined with standard physiotherapy (stretching, core stabilization) as needed for the specific patients. 
Comparator Agent  Sham Short Wave Diathermy group   Identical setup of Short wave diathermy (SWD) group but with no active SWD emission: - Pulsed SWD (27.12 MHz, 100–150 W, 20 min per session, 3 session per week for 4 weeks) using Webstar-500 SWD machine. - Combined with standard physiotherapy (stretching, core stabilization) as needed for the specific patients.  
Comparator Agent  Short Wave Diathermy  Short Wave Diathermyh (SWD) Group: - Pulsed SWD (27.12 MHz, 100–150 W, 20 min per session, 3 session per week for 4 weeks) using Webstar-500 SWD machine. - Combined with standard physiotherapy (stretching, core stabilization) as needed for the specific patients.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. A primary complaint of either:
a. low back pain, defined as pain between the inferior costal margin and the inferior gluteal fold with or without referral into the leg(s)
or
b. referred leg pain without back pain, defined as predominately unilateral posterior leg pain extending below the knee, or anterior thigh pain, presumed to be of lumbar spine origin.
2. Duration of the current episode of primary complaint lasting for greater than 3 months (chronic stage of the injury)
3. Aged between 18 and 65 (inclusive)
4. Fluency in Bangla or English sufficient to complete questionnaires and to enable understanding of the intervention
5. Agreeing to refrain from other interventions wherever possible for the 10-week treatment period of the trial, aside from consultations with medical practitioners, medication, and
any exercises already being undertaken
 
 
ExclusionCriteria 
Details  1. Active cancer under current treatment, as the treatment of cancer may interfere with their ability to participate in the trial
2. Signs of cauda equina syndrome based on bladder or bowel disturbance and/or imaging
3. Current pregnancy, or childbirth within the last 6 months, as this could impair the ability to undertake exercises, and could also cause back and leg symptoms that are not related to
the subgroups under investigation
4. Spinal injections within the last 6 weeks, as we wish to study treatment effects independent of the effects of injections
5. Any history of lumbar spine surgery, as there is already considerable research evaluating the efficacy of post-surgical rehabilitation programs
6. A pain intensity score of less than 2/10 on a 0-10 numerical rating scale due to low severity
7. Minimal activity limitation, evidenced by a baseline ability to walk, sit, and stand for one hour or more and no sleep disturbance at night, as we wish to exclude people with low
severity
8. Already received more than 5 sessions of physiotherapy with any of the treating physiotherapists before enrolment, as this could influence treatment expectations in patients
9. Inability to walk safely, such as severe foot drop causing regular tripping, as the interventions in the trial include walking for most participants
10. Planned absence of more than one week during the treatment period (such as extended holidays) 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1. Back pain intensity (0-10 numerical rating
scale)
2. Leg pain intensity (0-10 numerical rating
scale)
3. Activity limitation: Oswestry Disability
Index V2.1 with sex life question replaced
by a work or housework question 
Baseline, 4 weeks, 12 weeks and 24 weeks. 
 
Secondary Outcome  
Outcome  TimePoints 
1. Brief Pain Inventory: pain severity and pain
interference
2. Global rating of change scale (7-point Likert
scale)
3. Satisfaction with treatment (5-point Likert
scale)
4. Interference with work or housework in the
past week (5-point Likert scale), and number
of work hours missed in the last 7 days
5. Orebro ¨
Musculoskeletal Pain Screening
Questionnaire Short Form (¨OMPSQ-SF)
6. Quality of life (EuroQol-5D-5L)
7. Depression Anxiety and Stress Scale (DASS-
21)
8. Pain Self-Efficacy questionnaire (PSEQ)
9. Pain Catastrophizing Scale (PCS)
10. Insomnia Severity Index (ISI)
11. Central Sensitisation Inventory 9 (CSI-9)
12. Clinical inflammation score
13. Treatment Credibility Questionnaire
14. Healthcare utilisation (participant diary
tracking health service utilisation,
imaging, medication) 
Baseline, 4 weeks, 12 weeks and 24 weeks. 
 
Target Sample Size   Total Sample Size="208"
Sample Size from India="0" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   19/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  19/11/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Title: Effectiveness of Shortwave Diathermy in Patients with Chronic Low Back Pain: A Randomized Single-Blinded Multicenter Clinical Trial

Summary: This is a proposed randomized, single-blinded, multicenter clinical trial designed to evaluate the effectiveness of Shortwave Diathermy (SWD) for chronic low back pain (CLBP). The study will enroll 140 adults with CLBP and randomly assign them to one of two groups: one receiving active SWD plus standard physiotherapy and the other receiving sham SWD plus standard physiotherapy.

The primary goal is to determine if active SWD is more effective than a sham procedure at reducing pain (measured on a Visual Analog Scale) and improving functional outcomes over a 4-week intervention period with a 3-month follow-up. The study aims to provide high-quality evidence to either support the integration of SWD into CLBP treatment guidelines or to discourage its use if it proves ineffective.

 
Close